Clinical practice recommendations for haematopoietic cell transplantation and CAR-T therapy, new for 2025

The European Society for Blood and Marrow Transplantation (EBMT) has released its ninth special report on indications for hematopoietic cell transplantation (HCT) and chimeric antigen receptor T-cell (CAR-T) therapy. The report provides updated guidance for clinicians treating hematological diseases, solid tumors, and immune disorders.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup